http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20000031977-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9673d6f44e8fcbc4593ee374bd4b0bf2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4375
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
filingDate 1998-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdfcdd96830391c8db0c08b7695caaa0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff95572879e5a3a839874bb66d729448
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b35db4f6f25ee83891d38258ce6088cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2ea1fb232271dee204925884064333d
publicationDate 2000-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20000031977-A
titleOfInvention Inhibition of Cancer Cell Proliferation Using Berberubin
abstract The present invention is an isoquinoline alkaloid compound extracted from Berberis vulgaris L., which not only promotes DNA cleavage mediated by topoisomerase II but also catalyzes topoisomerase II. It relates to a method of inhibiting the proliferation of cancer cells using berberubin to inhibit the activity. Berberubin is a reversible topoisomerase II-mediated DNA cleavage / reconnection reaction that traps topoisomerase II by trapping nicked circular DNA that is an intermediate between linear and circular DNA. Inhibition of DNA recombination, and directly inhibits the enzyme activity of topoisomerase even in the step before formation of the topoisomerase II-DNA cleavage complex. Thus, Berberubin is of value as a new anticancer agent targeting topoisomerase II. In addition, since berrubin has a mechanism of action different from that of the conventional topoisomerase II poison, it is expected to overcome drug resistance due to repeated use of conventional anticancer drugs.
priorityDate 1998-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408096083
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID258209
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483315
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413823327
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID258209
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3000671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450374235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526468
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72704
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504623
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415749914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23668817
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411840661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416215471
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP36375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2179
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP06873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2353
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119081
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3213
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2719

Total number of triples: 36.